Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Net Income (Common)
Meridian Bioscience Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Net Income (Common)
$42.5m
|
CAGR 3-Years
20%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Net Income (Common)
$290.8m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Net Income (Common)
-$95m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
Align Technology Inc
NASDAQ:ALGN
|
Net Income (Common)
$462.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
13%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Net Income (Common)
$460.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
See Also
What is Meridian Bioscience Inc's Net Income (Common)?
Net Income (Common)
42.5m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Net Income (Common) amounts to 42.5m USD.
What is Meridian Bioscience Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
15%
Over the last year, the Net Income (Common) growth was -41%. The average annual Net Income (Common) growth rates for Meridian Bioscience Inc have been 20% over the past three years , 15% over the past five years .